Register entry

Suzhou Lixin Pharmaceutical Co., Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
5
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Suzhou Lixin Pharmaceutical Co., Ltd.21 Tangxi Road, Suzhou, Jiangsu 215151, China (CHN)Analytical testing, Active ingredient (API) manufacture3008251350529047247
Catalogue

Drug listings by form and route

5

5 active NDC listings: 5 bulk ingredient. By marketing category: BULK INGREDIENT 3, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 2.

Dosage formNDCs
powder5
RouteNDCs
Labeller name on the listingNDCs
suzhou lixin pharmaceutical co., ltd.5
Catalogue

Marketed products

5
BrandGeneric nameForm / routeNDC
-Idebenonepowder29930-007BULK INGREDIENT
-Nilotinib Hydrochloride Monohydratepowder29930-008BULK INGREDIENT
-Pemetrexed Disodiumpowder29930-243BULK INGREDIENT
-semaglutidepowder29930-009BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-tirzepatidepowder29930-010BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Neighbours

Registered in the same town

10
Compare

Comparable companies in China

Enquiry

Common questions

Is Suzhou Lixin Pharmaceutical Co., Ltd. FDA approved?
Suzhou Lixin Pharmaceutical Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Suzhou Lixin Pharmaceutical Co., Ltd.'s drugs manufactured?
The FDA register lists Suzhou. Registered operations: analytical testing, active ingredient (API) manufacture.
What drugs does Suzhou Lixin Pharmaceutical Co., Ltd. make?
5 products are listed under Suzhou Lixin Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.